Talk:Xanthinol

This is the talk page for discussing improvements to the Xanthinol article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Xanthinol.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Merger_proposal

I propose that the article Xantinol nicotinate be merged into this article. It seems that the active component of Xantinol nicotinate is the xantinol and it just so happens that the nicotinate salt ([[1]]) is the commonly used from in medicines. As there is very little content in either article at the moment I can't see a particular reason why two distinct pages would be needed. --The chemistds (talk) 13:59, 13 January 2014 (UTC)[reply]

Since both xantinol and nicotinic acid (niacin) are vasodilators, xantinol nicotinate has two active ingredients and could be considered a combination drug which are typically given their own articles on Wikipedia. -- Ed (Edgar181) 14:16, 13 January 2014 (UTC)[reply]

Buerger Disease

Xanthine Nicotinate Inj Is Now Used To Promote Ulcer Healing ,Helps to Increase claudication Distance as temporary Change. — Preceding unsigned comment added by VinayWin243 (talk • contribs) 03:45, 21 August 2018 (UTC)[reply]